Spartan Fund Management’s Lux Health Tech Acquisition Corp. Units LUXAU Stock Holding History

Spartan Fund Management’s Portfolio LUXAU Stock Details LUXAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,405	Closed	-$14K	–	546
2022 Q2	$14K	Hold	1,405	–	–	﹤0.01%	380
2022 Q1	$18K	Buy	+1,405	New	+$14K	﹤0.01%	393

Other funds holding LUXAU

BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Spartan Fund Management's LUXAU Position: Q3 2022 in Review

Spartan Fund Management sold out of Lux Health Tech Acquisition Corp. Units (LUXAU) in Q3 2022, closing a stake of 1,405 shares — an estimated $14K sold.

Spartan Fund Management first reported a position in LUXAU in Q1 2022 and held it in 2 quarters. The position peaked at $18K in Q1 2022. 9 funds tracked by Wall St. Rank hold LUXAU as of Q3 2022.

Spartan Fund Management reported no remaining Lux Health Tech Acquisition Corp. Units position as of Q3 2022 after selling out during the quarter.
Spartan Fund Management sold 1,405 Lux Health Tech Acquisition Corp. Units shares in Q3 2022, an estimated $14K.
Spartan Fund Management first reported a position in Lux Health Tech Acquisition Corp. Units in Q1 2022 and held it in 2 quarters.
Spartan Fund Management's Lux Health Tech Acquisition Corp. Units position peaked at $18K in Q1 2022.
9 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Units as of Q3 2022.

Based on Spartan Fund Management's 13F filing for Q3 2022, filed 26 Oct 2022.